291 related articles for article (PubMed ID: 22819428)
1. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation.
Van Mieghem NM; Tchetche D; Chieffo A; Dumonteil N; Messika-Zeitoun D; van der Boon RM; Vahdat O; Buchanan GL; Marcheix B; Himbert D; Serruys PW; Fajadet J; Colombo A; Carrié D; Vahanian A; de Jaegere PP
Am J Cardiol; 2012 Nov; 110(9):1361-7. PubMed ID: 22819428
[TBL] [Abstract][Full Text] [Related]
2. Transfemoral aortic valve implantation new criteria to predict vascular complications.
Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
[TBL] [Abstract][Full Text] [Related]
3. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
[TBL] [Abstract][Full Text] [Related]
4. Vascular complications in steroid treated patients undergoing transfemoral aortic valve implantation.
Fink N; Segev A; Barbash I; Bogdan A; Hamdan A; Mazin I; Maor E; Hay I; Guetta V; Fefer P
Catheter Cardiovasc Interv; 2016 Feb; 87(2):341-6. PubMed ID: 26010839
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
[TBL] [Abstract][Full Text] [Related]
6. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
[TBL] [Abstract][Full Text] [Related]
7. Management of vascular complications following transcatheter aortic valve implantation.
Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
[TBL] [Abstract][Full Text] [Related]
8. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
Saleh N; De Palma R; Settergren M; Rück A
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
[TBL] [Abstract][Full Text] [Related]
9. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
Genereux P; Kodali S; Leon MB; Smith CR; Ben-Gal Y; Kirtane AJ; Daneault B; Reiss GR; Moses JW; Williams MR
JACC Cardiovasc Interv; 2011 Aug; 4(8):861-7. PubMed ID: 21851899
[TBL] [Abstract][Full Text] [Related]
11. Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
Kahlert P; Al-Rashid F; Plicht B; Konorza T; Neumann T; Thielmann M; Wendt D; Erbel R; Eggebrecht H
Catheter Cardiovasc Interv; 2013 Feb; 81(2):E139-50. PubMed ID: 22553193
[TBL] [Abstract][Full Text] [Related]
12. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience.
Van Mieghem NM; Nuis RJ; Piazza N; Apostolos T; Ligthart J; Schultz C; de Jaegere PP; Serruys PW
EuroIntervention; 2010 Jan; 5(6):673-9. PubMed ID: 20142217
[TBL] [Abstract][Full Text] [Related]
13. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
[TBL] [Abstract][Full Text] [Related]
14. Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation.
El-Mawardy M; Schwarz B; Landt M; Sulimov D; Kebernik J; Allali A; Becker B; Toelg R; Richardt G; Abdel-Wahab M
EuroIntervention; 2017 Jan; 12(13):1667-1673. PubMed ID: 28106001
[TBL] [Abstract][Full Text] [Related]
15. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure.
Nakamura M; Chakravarty T; Jilaihawi H; Doctor N; Dohad S; Fontana G; Cheng W; Makkar RR
Catheter Cardiovasc Interv; 2014 Aug; 84(2):293-300. PubMed ID: 23873857
[TBL] [Abstract][Full Text] [Related]
16. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
[TBL] [Abstract][Full Text] [Related]
17. Predictors and incidence of access site complications in transcatheter aortic valve implantation with the use of new delivery systems.
Sari C; Ayhan H; Aslan AN; Durmaz T; Keleş T; Baştuğ S; Bayram NA; Bilen E; Kasapkara HA; Bozkurt E
Perfusion; 2015 Nov; 30(8):666-74. PubMed ID: 25795681
[TBL] [Abstract][Full Text] [Related]
18. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of surgical cutdown versus percutaneous access in transfemoral TAVR.
Holper EM; Kim RJ; Mack M; Brown D; Brinkman W; Herbert M; Stewart W; Vance K; Bowers B; Dewey T
Catheter Cardiovasc Interv; 2014 Feb; 83(3):457-64. PubMed ID: 23703878
[TBL] [Abstract][Full Text] [Related]
20. Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis.
Abu Saleh WK; Tang GH; Ahmad H; Cohen M; Undemir C; Lansman SL; Reyes M; Barker CM; Kleiman NS; Reardon MJ; Ramlawi B
Catheter Cardiovasc Interv; 2016 Jul; 88(1):135-43. PubMed ID: 26603266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
